Carboplatin-loaded PLGA microspheres for intracerebral implantation: In vivo characterization

被引:24
作者
Chen, W
He, J
Olson, JJ
Lu, DR [1 ]
机构
[1] Univ Georgia, Coll Pharm, Dept Pharmaceut, Athens, GA 30602 USA
[2] Emory Univ, Sch Med, Neurosurg Sect, Atlanta, GA USA
基金
美国国家卫生研究院;
关键词
biodegradable and injectable microspheres; carboplatin; intracerebral implantation; PLGA;
D O I
10.3109/10717549709052017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Carboplatin is a potent anticancer agent that has shown efficacy in clinical trials against malignant glioma, one of the most deadly cancers in humans. However, a high systemic dose is required to achieve an effective concentration in the brain because of the presence of the blood-brain barrier (BBB), Such a high dose can cause many side effects. Local delivery of antitumor agents to the brain using injectable and biodegradable microspheres is a new strategy for the treatment of malignant glioma. This method is able to bypass the BBB and allows maximal local exposure and minimal systemic exposure to avoid the severe side effects of carboplatin. Delivering sustained-release microspheres directly to the tumor site could also control local tumor recurrence and improve survival. In the present studies, carboplatin-loaded microspheres were delivered intracerebrally in rats. No signs of systemic or neurologic toxicity associated with the microspheres implanted in the rat brain were observed. The in vivo release of carboplatin followed apparently zero-order release kinetics up to 30 days. The surface characteristics of the microspheres retrieved from the rat brains changed with the progress of polymer biodegradation. Implantation of the microspheres evoked a transient and localized inflammatory reaction that was well tolerated by the animals.
引用
收藏
页码:301 / 311
页数:11
相关论文
共 19 条
[1]  
CHEN W, UNPUB INT J PHARM
[2]  
DODION P, 1988, CANCER CHEMOTH PHARM, V22, P80
[3]  
GAYNON PS, 1990, CANCER, V66, P2465, DOI 10.1002/1097-0142(19901215)66:12<2465::AID-CNCR2820661204>3.0.CO
[4]  
2-N
[5]   PHARMACOKINETIC STUDY OF CEREBROSPINAL-FLUID PENETRATION OF CIS-DIAMMINEDICHLOROPLATINUM (II) [J].
GORMLEY, PE ;
GANGJI, D ;
WOOD, JH ;
POPLACK, DG .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1981, 5 (04) :257-260
[6]  
HILL BT, 1988, INVEST NEW DRUG, V6, P11
[7]   ASSUMPTIONS IN THE RADIOTHERAPY OF GLIOBLASTOMA [J].
HOCHBERG, FH ;
PRUITT, A .
NEUROLOGY, 1980, 30 (09) :907-911
[8]  
Kou Jim H., 1995, Pharmaceutical Research (New York), V12, pS194
[9]  
MAHTA RC, 1994, J CONTROL RELEASE, V29, P375
[10]   Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7 [J].
Matsukado, K ;
Inamura, T ;
Nakano, S ;
Fukui, M ;
Bartus, RT ;
Black, KL .
NEUROSURGERY, 1996, 39 (01) :125-133